26 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... HumanPapillomavirus #IDSA ... #Prevention #Treatment ... #management #opportunistic
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
Initiation of ART in HIV ... patients with Opportunistic ... regardless of CD4 • Cryptococcal ... of starting OI treatment ... #Opportunistic
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Infections in HIV-AIDS ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Trypanosomiasis) in HIV-AIDS ... Trypanosomiasis #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... #management #opportunistic
Papilledema on Fundoscopy Ocular Examination

31 year old male with cryptococcal meningitis. CD4 count 44, 1 year
Papilledema on Fundoscopy ... old male with cryptococcal ... year without ART treatment ... PhysicalExam #clinical #video ... ophthalmology #Fundoscopy
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... Encephalitis in HIV-AIDS ... #Prevention #Treatment ... #opportunistic
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... and uncontrolled HIV ... recommended for KS treatment ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... candida #mucosal #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Infections in HIV-AIDS ... • Continue treatment ... #IDSA #Prevention ... #opportunistic